What management recommendations should I give my patient with hidradenitis suppurativa to improve their condition?

Management Recommendations for Hidradenitis Suppurativa

Your patient should immediately begin a multimodal treatment approach combining antiseptic washes, topical therapies, and systemic antibiotics or biologics based on disease severity, while simultaneously addressing modifiable risk factors and planning for procedural interventions if inflammatory lesions persist beyond 8-12 weeks. 1

Immediate Self-Care Measures

Daily Hygiene and Topical Management

• Use antiseptic washes daily with chlorhexidine, benzoyl peroxide, or zinc pyrithione to reduce bacterial colonization and inflammation 1
• Apply benzoyl peroxide in combination with any topical antibiotics to reduce the risk of Staphylococcus aureus resistance 1
• For mild disease (Hurley stage I-II), apply topical clindamycin 1% solution which reduces pustules, though it has limited effect on inflammatory nodules and abscesses 1
• Consider resorcinol 15% cream applied twice daily during flares and daily between flares, which reduces pain and duration of abscesses, though watch for irritant dermatitis 1

Lifestyle Modifications

• Achieve and maintain weight loss if overweight, as obesity is a significant modifiable risk factor 2, 3
• Stop smoking immediately as tobacco use worsens disease severity and treatment response 2, 3
• Wear loose-fitting, breathable clothing to reduce friction and moisture in affected areas 2
• Avoid shaving or aggressive hair removal in affected regions 2

Medical Treatment Algorithm Based on Disease Severity

Mild Disease (IHS4 ≤3 or Hurley Stage I)

• Start with oral tetracyclines (doxycycline 100mg twice daily or minocycline) for 12 weeks as first-line systemic therapy 1
• Doxycycline is preferred over minocycline due to fewer severe side effects like pseudotumor cerebri 1
• Continue long-term maintenance if effective 1
• Add intralesional triamcinolone (10 mg/mL, 0.2-2.0 mL) for acute inflamed lesions, which significantly reduces pain within 1 day 1

Moderate Disease (IHS4 4-10 or Hurley Stage II)

• Initiate combination clindamycin 300mg + rifampin 300mg twice daily for 8-12 weeks, which achieves 71-93% response rates 1
• This combination is more effective than tetracycline monotherapy and can be repeated intermittently 1
• Alternative: 5-day intravenous clindamycin therapy can shorten systemic antibiotic duration 4, 5
• For female patients, add hormonal therapy (combined oral contraceptives containing estrogen, spironolactone, or cyproterone acetate) as adjunctive treatment 1
• Avoid progestogen-only contraceptives as they may worsen disease 1

Severe Disease (IHS4 >10 or Hurley Stage III)

• Do not delay biologic therapy - aggressive early treatment is critical to capture the window of opportunity before irreversible sinus tract formation 3, 6
• First-line biologics approved for HS:
  • Adalimumab (approved for ages 12+) 1, 4, 5
  • Secukinumab 4, 5
  • Bimekizumab 4, 5
• Use systemic antibiotics as adjunctive therapy only, not monotherapy, due to lower response rates and increased recurrence in severe disease 1
• For rescue therapy or bridge to surgery: triple antibiotic therapy with moxifloxacin 400mg daily + metronidazole 500mg three times daily + rifampin 300mg twice daily for 1-12 months (stop metronidazole at 6 weeks to avoid neurologic toxicity) 1
• Alternative rescue: intravenous ertapenem 1g daily for 6 weeks as a one-time course 1

Critical Timing Considerations

Sequential monotherapy is strongly discouraged - always use combination approaches for moderate-to-severe disease 3

Do not pursue medical therapy for too long - if inflammatory lesions persist beyond 8-12 weeks despite aggressive medical management, proceed to surgical consultation for definitive treatment of sinus tracts 6

The predominantly non-inflammatory form with established sinus tracts requires surgical intervention as medical therapy alone is insufficient 1, 4, 5

Pain Management

• Address pain aggressively as HS significantly impacts quality of life 2, 7
• Intralesional steroids provide rapid pain relief within 24 hours for acute flares 1
• Consider multimodal pain management including topical analgesics, systemic medications, and procedural interventions 7

Comorbidity Screening

• Screen for metabolic syndrome, diabetes, inflammatory bowel disease, and depression shortly after diagnosis 2
• Consider metformin in appropriate patients with metabolic dysfunction 1

Treatment Stacking Approach

The most effective strategy combines:

• Daily antiseptic washes 1
• Topical therapies for localized lesions 1
• Systemic antibiotics or biologics based on severity 1, 4
• Hormonal therapy in appropriate female patients 1
• Intralesional steroids for acute flares 1
• Surgical intervention for established sinus tracts 1, 4, 6
• Lifestyle modifications 2, 3

Common Pitfalls to Avoid

• Do not use topical clindamycin without benzoyl peroxide due to high risk of bacterial resistance 1
• Avoid triclosan-containing washes in pregnant patients due to endocrine-disrupting effects 1
• Do not delay biologic therapy in moderate-to-severe disease - early aggressive treatment prevents irreversible tissue damage 3, 6
• Stop metronidazole at 6 weeks in triple therapy to prevent neurologic toxicity 1
• Balance antibiotic duration with resistance risk, as recurrence after cessation is frequent 1